- Home
- HUMAW vs CENX Comparison
HUMAW vs CENX Comparison
Compare HUMAW & CENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- CENX
- Stock Information
- Founded
- HUMAW 2004
- CENX 1995
- Country
- HUMAW United States
- CENX United States
- Employees
- HUMAW 220
- CENX N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- CENX Aluminum
- Sector
- HUMAW Health Care
- CENX Industrials
- Exchange
- HUMAW Nasdaq
- CENX Nasdaq
- Market Cap
- HUMAW N/A
- CENX 1.8B
- IPO Year
- HUMAW N/A
- CENX 1996
- Fundamental
- Price
- HUMAW $0.41
- CENX $18.26
- Analyst Decision
- HUMAW
- CENX Strong Buy
- Analyst Count
- HUMAW 0
- CENX 3
- Target Price
- HUMAW N/A
- CENX $23.00
- AVG Volume (30 Days)
- HUMAW 14.2K
- CENX 1.5M
- Earning Date
- HUMAW 03-21-2025
- CENX 08-07-2025
- Dividend Yield
- HUMAW N/A
- CENX N/A
- EPS Growth
- HUMAW N/A
- CENX N/A
- EPS
- HUMAW N/A
- CENX 1.22
- Revenue
- HUMAW N/A
- CENX $2,364,700,000.00
- Revenue This Year
- HUMAW N/A
- CENX $7.19
- Revenue Next Year
- HUMAW N/A
- CENX $3.99
- P/E Ratio
- HUMAW N/A
- CENX $14.81
- Revenue Growth
- HUMAW N/A
- CENX 11.41
- 52 Week Low
- HUMAW $1.18
- CENX $11.40
- 52 Week High
- HUMAW $1.34
- CENX $25.39
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- CENX 51.41
- Support Level
- HUMAW N/A
- CENX $17.22
- Resistance Level
- HUMAW N/A
- CENX $19.12
- Average True Range (ATR)
- HUMAW 0.00
- CENX 0.79
- MACD
- HUMAW 0.00
- CENX -0.10
- Stochastic Oscillator
- HUMAW 0.00
- CENX 42.68
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.
About CENX Century Aluminum Company
Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.